Stockreport

Marinus up 58% premarket on positive ganaloxone data [Seeking Alpha]

Marinus Pharmaceuticals, Inc.  (MRNS) 
Last marinus pharmaceuticals, inc. earnings: 11/6 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.marinuspharma.com/investor-relations
PDF Marinus up 58% premarket on positive ganaloxone data Nano cap Marinus Pharmaceuticals (NASDAQ: MRNS 58% Phase 2 clinical trial status epilepticus The study met the prima [Read more]